These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 22386132

  • 1. Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast.
    Linda A, Zuiani C, Londero V, Cedolini C, Girometti R, Bazzocchi M.
    Eur J Radiol; 2012 Nov; 81(11):3201-7. PubMed ID: 22386132
    [Abstract] [Full Text] [Related]

  • 2. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
    Kim SJ, Morris EA, Liberman L, Ballon DJ, La Trenta LR, Hadar O, Abramson A, Dershaw DD.
    AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
    [Abstract] [Full Text] [Related]

  • 3. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of probably benign breast MRI lesions.
    Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD.
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [Abstract] [Full Text] [Related]

  • 5. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD.
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [Abstract] [Full Text] [Related]

  • 6. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM, Nguyen ET, Jaffey J.
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [Abstract] [Full Text] [Related]

  • 7. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, Bazzocchi M.
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [Abstract] [Full Text] [Related]

  • 8. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis.
    Wiener JI, Schilling KJ, Adami C, Obuchowski NA.
    AJR Am J Roentgenol; 2005 Mar; 184(3):878-86. PubMed ID: 15728612
    [Abstract] [Full Text] [Related]

  • 9. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD.
    Breast J; 2007 Mar; 13(6):545-50. PubMed ID: 17983393
    [Abstract] [Full Text] [Related]

  • 10. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA.
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [Abstract] [Full Text] [Related]

  • 11. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended.
    Meissnitzer M, Dershaw DD, Lee CH, Morris EA.
    AJR Am J Roentgenol; 2009 Oct; 193(4):1025-9. PubMed ID: 19770325
    [Abstract] [Full Text] [Related]

  • 12. Benign (BI-RADS 2) lesions in breast MRI.
    Spick C, Szolar DH, Tillich M, Reittner P, Preidler KW, Baltzer PA.
    Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
    [Abstract] [Full Text] [Related]

  • 13. Cancer yield of probably benign breast MR examinations.
    Eby PR, Demartini WB, Peacock S, Rosen EL, Lauro B, Lehman CD.
    J Magn Reson Imaging; 2007 Oct; 26(4):950-5. PubMed ID: 17896380
    [Abstract] [Full Text] [Related]

  • 14. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, Fezoulidis IV.
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [Abstract] [Full Text] [Related]

  • 15. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E.
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [Abstract] [Full Text] [Related]

  • 16. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A, Zuiani C, Londero V, Bazzocchi M.
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [Abstract] [Full Text] [Related]

  • 17. The BI-RADS breast magnetic resonance imaging lexicon.
    Molleran V, Mahoney MC.
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):171-85, vii. PubMed ID: 20494304
    [Abstract] [Full Text] [Related]

  • 18. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R.
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [Abstract] [Full Text] [Related]

  • 19. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV.
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [Abstract] [Full Text] [Related]

  • 20. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD, Baur A, Hattermann V, Hahn M, Vogel U, Claussen CD, Siegmann-Luz KC.
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.